BMC pregnancy and childbirth · 2025
Does vitamin B12 influence clinical pregnancy outcome in the follicular-phase GnRH agonist protocol?
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Xiaoning, Fu Kui, Zhang Ying, Jiang Shengfang, Zhang Changjun
Аннотация
PURPOSE: To investigate whether vitamin B12 levels affect IVF-ET pregnancy outcomes.
DESIGN: Single-center, retrospective, observational study.
DESIGN: Single-center, retrospective, observational study.
MAIN OUTCOME MEASURES: The primary outcome was the clinical pregnancy rate (CPR).
RESULTS: After adjusting for Age, BMI, AMH, number of oocytes retrieved, cleavage-stage embryos/blastocysts, and the number of transferred embryos, when the vitamin B12 value was ≤358.7 pg/ml, for every 10 pg/ml increase in the vitamin B12 value, the clinical pregnancy rate increased by 4% (OR=1.04, 95% CI=1.00, 1.08, P=0.03).
CONCLUSION: Within a specific range (≤358.7 pg/mL), serum vitamin B12 levels may modestly contribute to improved clinical pregnancy rates in women undergoing IVF-ET with the follicular-phase GnRH agonist protocol, though further validation is required to confirm its clinical significance.
TRIAL REGISTRATION: None.
DESIGN: Single-center, retrospective, observational study.
DESIGN: Single-center, retrospective, observational study.
MAIN OUTCOME MEASURES: The primary outcome was the clinical pregnancy rate (CPR).
RESULTS: After adjusting for Age, BMI, AMH, number of oocytes retrieved, cleavage-stage embryos/blastocysts, and the number of transferred embryos, when the vitamin B12 value was ≤358.7 pg/ml, for every 10 pg/ml increase in the vitamin B12 value, the clinical pregnancy rate increased by 4% (OR=1.04, 95% CI=1.00, 1.08, P=0.03).
CONCLUSION: Within a specific range (≤358.7 pg/mL), serum vitamin B12 levels may modestly contribute to improved clinical pregnancy rates in women undergoing IVF-ET with the follicular-phase GnRH agonist protocol, though further validation is required to confirm its clinical significance.
TRIAL REGISTRATION: None.